Editor's note: days ago, the first Zeiss pre-installed heparin-coated aspheric single-focus intraocular lens CT LUCIA 621P implantation in Boao Lecheng Aier Hospital in Hainan was successfully completed. This CT LUCIA 621P intraocular lens implantation surgery is a franchise surgical project carried out by Boao Lecheng Aier Eye Hospital, a "international clinical research base" located in the Lecheng Pilot Zone, and relies on the "first trial" policy of Lecheng .
Professor Chen Haibo completed the first pre-installed heparin-coated intraocular lens CT LUCIA 621P implantation
This operation was performed by Professor Chen Haibo, Vice President of the Hainan Province and Region of Aier Eye Group. Professor Chen Haibo returned to China with a doctorate degree from Yamanashi Medical University in 1997. He has 36 years of ophthalmology work history and 30,000 surgical experience. He has rich clinical experience in the diagnosis and treatment of glaucoma, cataract , excimer laser and common ophthalmology diseases. Currently, he serves as deputy chairman of the Hainan Ophthalmology Association, leader of the glaucoma group, and vice president of Hainan New Hope Aier Eye Hospital.
The first time I implanted pre-installed heparin-coated intraocular lens CT LUCIA 621P
The first feeling mentioned by Professor Chen Haibo is that the operation is very smooth, thanks to the full pre-installed design of this intraocular lens , although it is the first time I implant, the surgical process is very efficient and smooth. It also mentioned that the examination equipment and surgical equipment of Boao Lecheng Aier Eye Hospital are high-end, and the first implantation experience is very good.
Implanted pre-installed heparin-coated intraocular lens CT LUCIA 621P patients
"You can see two shelves standing on the roof in the woods in front of you, and you can see it clearly." On the first day after the operation, 68-year-old Uncle He took off the white gauze covering his left eye at Boao Lecheng Aier Eye Hospital. The day before yesterday, he had just undergone the first licensed implantation surgery for Zeiss pre-installed heparin-coated intraocular lens CT LUCIA 621P in China. His naked eye vision in his left eye has reached 1.0 after the operation, and he has felt the clear vision brought by the licensed new drug and equipment overnight.
66-year-old Aunt Li also felt the convenience of life brought by the operation. She opened a convenience store in the town and always admitted the mistakes of regular customers in the store. "I can only see the shadows of tall, short, fat and thin in a vague way." Aunt Li said, "I always felt busy before and couldn't take time to treat my eyes. I didn't expect that I could see so clearly the next day of the operation."
Professor Chen Haibo talked about why heparin-coated intraocular lens CT LUCIA 621P
talked about why Zeiss "pre-coated intraocular lens CT LUCIA for patients 621P", Professor Chen Haibo said that there are three advantages worth mentioning:
"First: The human eye is not a completely symmetrical state in our ideal. Many patients will face the risk of eccentric tilt after implanting the intraocular lens. Zeiss' intraocular lens has the patent of non-constant phase difference design, which can make up for the deviation of the intraocular lens in the eyes and bring good postoperative visual effects to patients. In the past, we have used a large number of Zeiss intraocular lenses that have been launched in China. The postoperative visual quality is very good, which brings a good diagnosis and treatment experience to patients.
Second: Heparin surface Coating treatment improves biocompatibility , reduces inflammatory response, and has a better preventive effect on long-term complications.
Third: Using a fully pre-installed design can reduce the risk of post-cataract infection while improving surgical efficiency. ”
Zeiss and Aier Eye Group will further deepen cooperation and introduce more advanced ophthalmic products to the Boao Aier Eye Hospital pioneer base, hoping to bring more cutting-edge international diagnosis and treatment experience to domestic patients through Lecheng's "first-test" policy and share global ophthalmic wisdom.
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-